PRMT3 regulates hepatic lipogenesis through direct interaction with LXRα

Diabetes

Volumn 64, Issue 1, 2015, Pages 60-71

  Kim, Dong Il ^a   Park, Min Jung ^a   Lim, Seul Ki ^b   Park, Jae Il ^a   Yoon, Kyung Chul ^c   Han, Ho Jae ^d   Gustafsson, Jan Åke ^e,f   Lim, Jae Hyang ^g   Park, Soo Hyun ^a  

^a Chonnam National University   (South Korea)

^b World Institute of Kimchi an Annex of Korea Food Research Institute   (South Korea)

^c Chonnam National University Medical School   (South Korea)

^d Seoul National University   (South Korea)

^e KAROLINSKA INSTITUTE   (Sweden)

^f University of Houston   (United States)

^g Ewha Womans University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; LIVER X RECEPTOR ALPHA; PALMITIC ACID; PROTEIN ARGININE METHYLTRANSFERASE; PROTEIN ARGININE METHYLTRANSFERASE 3; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; UNCLASSIFIED DRUG; LIVER X RECEPTOR; ORPHAN NUCLEAR RECEPTOR; PRMT3 PROTEIN, HUMAN; PROTEIN ARGININE N-METHYLTRANSFERASE 3, MOUSE;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID DIET; LIPID LIVER LEVEL; LIPOGENESIS; LIVER METABOLISM; MALE; METHYLATION; MOUSE; MOUSE MODEL; NONALCOHOLIC FATTY LIVER; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ANIMAL; CYTOLOGY; GENETICS; HEK293 CELL LINE; KNOCKOUT MOUSE; LIVER; METABOLISM; MIDDLE AGED; PHYSIOLOGY; REPORTER GENE;

AGED; ANIMALS; DIET, HIGH-FAT; FEMALE; FIBROBLASTS; GENES, REPORTER; HEK293 CELLS; HUMANS; LIPOGENESIS; LIVER; MALE; MICE, KNOCKOUT; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; ORPHAN NUCLEAR RECEPTORS; PALMITIC ACID; PROTEIN-ARGININE N-METHYLTRANSFERASES;

EID: 84920031309     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-1394     Document Type: Article

References (45)

1. Samuel VT, Liu ZX, Qu X, et al. Mechanism of hepatic insulin resistance in non-Alcoholic fatty liver disease. J Biol Chem 2004;279:32345-32353
2. Diraison F, Moulin P, Beylot M. Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-Alcoholic fatty liver disease. Diabetes Metab 2003;29:478-485
3. Repa JJ, Liang G, Ou J, et al. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes Dev 2000;14:2819-2830
4. Cha JY, Repa JJ. The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR. J Biol Chem 2007;282:743-751
5. Grefhorst A, Elzinga BM, Voshol PJ, et al. Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles. J Biol Chem 2002;277: 34182-34190
6. Talukdar S, Hillgartner FB. The mechanism mediating the activation of acetyl-coenzyme A carboxylase-Alpha gene transcription by the liver X receptor agonist T0-901317. J Lipid Res 2006;47:2451-2461
7. Joseph SB, Laffitte BA, Patel PH, et al. Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors. J Biol Chem 2002;277:11019-11025
8. Willy PJ, Umesono K, Ong ES, Evans RM, Heyman RA, Mangelsdorf DJ. LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev 1995;9:1033-1045
9. Hu X, Li S, Wu J, Xia C, Lala DS. Liver X receptors interact with corepressors to regulate gene expression. Mol Endocrinol 2003;17:1019-1026
10. Peet DJ, Turley SD, Ma W, et al. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell 1998;93: 693-704
11. Yecies JL, Zhang HH, Menon S, et al. Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways. Cell Metab 2011;14:21-32
12. Denechaud PD, Bossard P, Lobaccaro JM, et al. ChREBP, but not LXRs, is required for the induction of glucose-regulated genes in mouse liver. J Clin Invest 2008;118:956-964
13. Bedford MT, Clarke SG. Protein arginine methylation in mammals: who, what, and why. Mol Cell 2009;33:1-13
14. Usui M, Matsuoka H, Miyazaki H, Ueda S, Okuda S, Imaizumi T. Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure. Life Sci 1998;62:2425-2430
15. Chan NN, Chan JC. Asymmetric dimethylarginine (ADMA): A potential link between endothelial dysfunction and cardiovascular diseases in insulin resistance syndrome? Diabetologia 2002;45:1609-1616
16. Hong E, Lim Y, Lee E, Oh M, Kwon D. Tissue-specific and age-dependent expression of protein arginine methyltransferases (PRMTs) in male rat tissues. Biogerontology 2012;13:329-336
17. Choi D, Oh KJ, Han HS, et al. Protein arginine methyltransferase 1 regulates hepatic glucose production in a FoxO1-dependent manner. Hepatology 2012;56: 1546-1556
18. Han HS, Jung CY, Yoon YS, et al. Arginine methylation of CRTC2 is critical in the transcriptional control of hepatic glucose metabolism. Sci Signal 2014;7:ra19
19. Lee JH, Park GH, Lee YK, Park JH. Changes in the arginine methylation of organ proteins during the development of diabetes mellitus. Diabetes Res Clin Pract 2011;94:111-118
20. Krones-Herzig A, Mesaros A, Metzger D, et al. Signal-dependent control of gluconeogenic key enzyme genes through coactivator-Associated arginine methyltransferase 1. J Biol Chem 2006;281:3025-3029
21. Tang J, Gary JD, Clarke S, Herschman HR. PRMT 3, a type I protein arginine N-methyltransferase that differs from PRMT1 in its oligomerization, subcellular localization, substrate specificity, and regulation. J Biol Chem 1998;273:16935-16945
22. Potter KA, Simon JS, Velagapudi B, Capadona JR. Reduction of autofluorescence at the microelectrode-cortical tissue interface improves antibody detection. J Neurosci Methods 2012;203:96-105
23. Zhao X, Feng D, Wang Q, et al. Regulation of lipogenesis by cyclindependent kinase 8-mediated control of SREBP-1. J Clin Invest 2012;122:2417-2427
24. Zhao C, Dahlman-Wright K. Liver X receptor in cholesterol metabolism. J Endocrinol 2010;204:233-240
25. Zhang Y, Breevoort SR, Angdisen J, et al. Liver LXRa expression is crucial for whole body cholesterol homeostasis and reverse cholesterol transport in mice. J Clin Invest 2012;122:1688-1699
26. Jwa H, Choi Y, Park UH, Um SJ, Yoon SK, Park T. Piperine, an LXRa antagonist, protects against hepatic steatosis and improves insulin signaling in mice fed a high-fat diet. Biochem Pharmacol 2012;84:1501-1510
27. Liang H, Zhong Y, Zhou S, Li QQ. Palmitic acid-induced apoptosis in pancreatic b-cells is increased by liver X receptor agonist and attenuated by eicosapentaenoate. In Vivo 2011;25:711-718
28. Stenson BM, Rydén M, Steffensen KR, et al. Activation of liver X receptor regulates substrate oxidation in white adipocytes. Endocrinology 2009;150: 4104-4113
29. Han CY, Ki SH, Kim YW, et al. Ajoene, a stable garlic by-product, inhibits high fat diet-induced hepatic steatosis and oxidative injury through LKB1- dependent AMPK activation. Antioxid Redox Signal 2011;14:187-202
30. Uemura T, Goto T, Kang MS, et al. Diosgenin, the main aglycon of fenugreek, inhibits LXRa activity in HepG2 cells and decreases plasma and hepatic triglycerides in obese diabetic mice. J Nutr 2011;141:17-23
31. Kuang YL, Paulson KE, Lichtenstein AH, Lamon-Fava S. Regulation of the expression of key genes involved in HDL metabolism by unsaturated fatty acids. Br J Nutr 2012;108:1351-1359
32. Baranowski M. Biological role of liver X receptors. J Physiol Pharmacol 2008;59(Suppl. 7):31-55
33. Smith JJ, Rücknagel KP, Schierhorn A, et al. Unusual sites of arginine methylation in Poly(A)-binding protein II and in vitro methylation by protein arginine methyltransferases PRMT1 and PRMT3. J Biol Chem 1999;274:13229-13234
34. Wada K, Inoue K, Hagiwara M. Identification of methylated proteins by protein arginine N-methyltransferase 1, PRMT1, with a new expression cloning strategy. Biochim Biophys Acta 2002;1591:1-10
35. Lee S, Lee J, Lee SK, Lee JW. Activating signal cointegrator-2 is an essential adaptor to recruit histone H3 lysine 4 methyltransferases MLL3 and MLL4 to the liver X receptors. Mol Endocrinol 2008;22:1312-1319
36. Yu H, Wu J, Yang M, et al. Involvement of liver X receptor alpha in histone modifications across the target fatty acid synthase gene. Lipids 2012;47:249-257
37. Swiercz R, Person MD, Bedford MT. Ribosomal protein S2 is a substrate for mammalian PRMT3 (protein arginine methyltransferase 3). Biochem J 2005;386: 85-91
38. Swiercz R, Cheng D, Kim D, Bedford MT. Ribosomal protein rpS2 is hypomethylated in PRMT3-deficient mice. J Biol Chem 2007;282:16917-16923
39. Handrkova H, Petrak J, Halada P, Pospisilova D, Cmejla R. Tyrosine 87 is vital for the activity of human protein arginine methyltransferase 3 (PRMT3). Biochim Biophys Acta 2011;1814:277-282
40. Tavanez JP, Bengoechea R, Berciano MT, Lafarga M, Carmo-Fonseca M, Enguita FJ. Hsp70 chaperones and type I PRMTs are sequestered at intranuclear inclusions caused by polyalanine expansions in PABPN1. PLoS ONE 2009;4: e6418
41. Di Lorenzo A, Bedford MT. Histone arginine methylation. FEBS Lett 2011; 585:2024-2031
42. Joseph SB, McKilligin E, Pei L, et al. Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc Natl Acad Sci U S A 2002;99:7604-7609
43. Chuu CP, Hiipakka RA, Kokontis JM, Fukuchi J, Chen RY, Liao S. Inhibition of tumor growth and progression of LNCaP prostate cancer cells in athymic mice by androgen and liver X receptor agonist. Cancer Res 2006;66:6482-6486
44. Gao M, Bu L, Ma Y, Liu D. Concurrent activation of liver X receptor and peroxisome proliferator-Activated receptor alpha exacerbates hepatic steatosis in high fat diet-induced obese mice. PLoS ONE 2013;8:e65641
45. Kratzer A, Buchebner M, Pfeifer T, et al. Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia. J Lipid Res 2009;50:312-326